Bronx database sheds light on underdiagnosed heart condition in women and minorities

NCT ID NCT06257485

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study creates a database of 476 patients in the Bronx who were tested for transthyretin amyloid cardiomyopathy (ATTR-CM), a serious and often missed heart condition. Researchers collected health records, imaging results, and outcomes like hospitalizations and deaths. The goal is to better understand how ATTR-CM affects a racially and ethnically diverse group, including many women, who are often left out of similar studies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this registry could reveal how ATTR-CM affects women and diverse racial/ethnic groups, leading to better detection and care for these populations.

What could go wrong

This is an observational study, not a treatment trial. It only looks back at existing records, so it cannot prove cause and effect or test new therapies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRANSTHYRETIN CARDIAC AMYLOIDOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

wild type ATTR amyloidosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Montefiore Health System

    The Bronx, New York, 10467, United States